Tiziana D'Alessandro

Dr. Tiziana D'Alessandro

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
Nicole Dalia CiliaNicole Dalia Cilia
Nicole Dalia Cilia
Tiziana D'AlessandroTiziana D'Alessandro
Tiziana D'Alessandro
CSClaudio De Stefano
Claudio De Stefano
Francesco FontanellaFrancesco Fontanella
Francesco Fontanella
Mario MolinaraMario Molinara
Mario Molinara
Early diagnosis of neurodegenerative disorders, such as Alzheimer's Disease (AD), is very important to reduce their effects and to improve both quality and life expectancy of patients. In this context, it is generally agreed that handwriting is one of the first skills altered by the onset of such diseases. For this reason, the analysis of handwriting and the study of its alterations have become of great interest in order to formulate the diagnosis as soon as possible. A fundamental aspect for the use of these techniques is the definition of effective features, which allows the system to distinguish the natural alterations of handwriting due to age, from those caused by neurodegenerative disorders. Starting from these considerations, the aim of our study is to verify whether the combined use of both shape and dynamic features allows a decision support system to improve performance for AD diagnosis. To this purpose, starting from a database of on-line handwriting samples, we generated for each of them an off-line synthetic color image, where the color of each elementary trait encodes, in the three RGB channels, the dynamic information associated with that trait. In order to verify the importance and the specific role played by shape information, we also generated an off-line synthetic binary image for each handwriting sample, where background pixels have white color, while those corresponding to the traits have black color. Finally, we exploited the ability of Convolutional Neural Network (CNN) to automatically extract features on both color and binary images. We carried out a large set of experiments for comparing the results obtained by using on-line features with those obtained by using the off-line features provided by CNN on both color and binary images.

19 October 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
Caterina VicidominiCaterina Vicidomini
Caterina Vicidomini
Francesco FontanellaFrancesco Fontanella
Francesco Fontanella
Tiziana D'AlessandroTiziana D'Alessandro
Tiziana D'Alessandro
Giovanni Nicola RovielloGiovanni Nicola Roviello
Giovanni Nicola Roviello
Currently, the age structure of the world population is changing due to declining birth rates and increasing life expectancy. As a result, physicians worldwide have to treat an increasing number of age-related diseases, of which neurological disorders represent a significant part. In this context, there is an urgent need to discover new therapeutic approaches to counteract the effects of neurodegeneration on human health, and computational science can be of pivotal importance for more effective neurodrug discovery. The knowledge of the molecular structure of the receptors and other biomolecules involved in neurological pathogenesis facilitates the design of new molecules as potential drugs to be used in the fight against diseases of high social relevance such as dementia, Alzheimer’s disease (AD) and Parkinson’s disease (PD), to cite only a few. However, the absence of comprehensive guidelines regarding the strengths and weaknesses of alternative approaches creates a fragmented and disconnected field, resulting in missed opportunities to enhance performance and achieve successful applications. This review aims to summarize some of the most innovative strategies based on computational methods used for neurodrug development. In particular, recent applications and the state-of-the-art of molecular docking and artificial intelligence for ligand- and target-based approaches in novel drug design were reviewed, highlighting the crucial role of in silico methods in the context of neurodrug discovery for neurodegenerative diseases.

12 January 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
Francesco FontanellaFrancesco Fontanella
Francesco Fontanella
Tiziana D'AlessandroTiziana D'Alessandro
Tiziana D'Alessandro
ENEmanuele Nardone
Emanuele Nardone
CSClaudio De Stefano
Claudio De Stefano
Caterina VicidominiCaterina Vicidomini
Caterina Vicidomini
Giovanni Nicola RovielloGiovanni Nicola Roviello
Giovanni Nicola Roviello
This review examines the application of Artificial Intelligence (AI) in the discovery and optimisation of neuroprotective natural products (NPs) for neurodegenerative diseases (NDDs), emphasising the transition from general computational drug discovery to AI-specific approaches designed to address the chemical complexity and bioactivity profiles of natural compounds. The discussion encompasses relevant datasets, AI models, illustrative case studies, and emerging protein and biological targets that may serve as potential points of intervention for the prevention and treatment of NDDs. The review is organised to guide the reader from foundational knowledge to applied strategies; it begins by outlining the chemical and biological principles underlying neuroprotective NPs, then presents AI-driven computational frameworks for NP discovery, followed by a detailed examination of recent case studies in NDDs. Subsequent sections address the key challenges, opportunities, and future directions in the field, concluding with an evaluation of prospects for interdisciplinary collaboration across medicinal chemistry, neuroscience, and artificial intelligence.
1

9 October 2023
Verified
Book Chapter
Closed access
PDF file
Tiziana D'AlessandroTiziana D'Alessandro
Tiziana D'Alessandro
CCCristina Carmona-Duarte
Cristina Carmona-Duarte
CSClaudio De Stefano
Claudio De Stefano
MDMoises Diaz
Moises Diaz
MFMiguel Angel Ferrer
Miguel Angel Ferrer
FFFrancesco Fontanella
Francesco Fontanella


21 January 2024
Verified
Book Chapter
Closed access
PDF file
Nicole Dalia CiliaNicole Dalia Cilia
Nicole Dalia Cilia
Tiziana D'AlessandroTiziana D'Alessandro
Tiziana D'Alessandro
CSClaudio De Stefano
Claudio De Stefano
Francesco FontanellaFrancesco Fontanella
Francesco Fontanella
IMIsabelle Marthot-Santaniello
Isabelle Marthot-Santaniello
Alessandra Scotto di FrecaAlessandra Scotto di Freca
Alessandra Scotto di Freca
1